Clinical Trials Logo

Filter by:
NCT ID: NCT01125215 Unknown status - Clinical trials for Painful Diabetic Neuropathy

Capsaicin Nanoparticle in Patient With Painful Diabetic Neuropathy

Start date: September 2009
Phase: Phase 2/Phase 3
Study type: Interventional

The objectives of this study are to determine efficacy and safety of 0.75% topical capsaicin nanoparticle preparation versus placebo in patient with painful diabetic neuropathy.

NCT ID: NCT01123993 Completed - Sleep Clinical Trials

The Effect of Thai Traditional Music on Cognitive Function, Psychological Health and Quality of Sleep Among Thai Older Individuals With Dementia

Start date: February 2010
Phase: Phase 3
Study type: Interventional

To determine the effect of Thai traditional music on cognitive function, psychological health and quality of sleep among Thai older individuals with dementia.

NCT ID: NCT01123590 Completed - Clinical trials for Clinical Presentations

Characteristics of Patients With Thymoma in Chulalongkorn Hospital

Start date: November 2009
Phase: N/A
Study type: Observational

The purpose of this study is to study characteristics of patients with thymoma in Chulalongkorn hospital between 2003-2007.

NCT ID: NCT01122303 Active, not recruiting - Clinical trials for Stevens-Johnson Syndrome

Corneal Epitheliotropic Factors in Autologous Serum Eye Drops in Nonautoimmune and Stevens-Johnson Syndrome With Dry Eye

Start date: December 2009
Phase: N/A
Study type: Observational

Autologous serum eye drops (ASE) have been becoming popular in treatment of severe dry eye for the past decade. One of the most beneficial properties of the ASE over artificial eye drops is the epitheliotropic capacity owing to the presence of growth factors and other proteins. There have been reports on alteration of serum growth factors in autoimmune diseases such as rheumatoid arthritis. Alteration in serum growth factors may lead to different therapeutic effect of ASE. We therefore would like to know if there are any alteration growth factors, epidermal growth factor (EGF), transforming growth factor-beta1 (TGF-β1), transforming growth factor-beta2 (TGF-β2), and fibronectin, in ASE from Stevens-Johnson syndrome (SJS) patients with dry eye, which constitutes a major group of ASE usage in Siriraj Hospital, as compared with non-autoimmune dry eye. We also study stability of these factors following different storage conditions.

NCT ID: NCT01121393 Completed - Clinical trials for Carcinoma, Non-Small-Cell Lung

BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC)

Start date: April 19, 2010
Phase: Phase 3
Study type: Interventional

To investigate the efficacy and safety of BIBW 2992 compared to standard first-line chemotherapy in patients with stage IIIB or IV adenocarcinoma of the lung harbouring an EGFR activating mutation

NCT ID: NCT01120184 Completed - Breast Cancer Clinical Trials

A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Participants With Metastatic Breast Cancer (MARIANNE)

Start date: July 31, 2010
Phase: Phase 3
Study type: Interventional

This randomized, 3-arm, multicenter, phase III study will evaluate the efficacy and safety of trastuzumab emtansine (T-DM1) with pertuzumab or trastuzumab emtansine (T-DM1) with pertuzumab-placebo (blinded for pertuzumab), versus the combination of trastuzumab (Herceptin) plus taxane (docetaxel or paclitaxel) in participants with HER2-positive progressive or recurrent locally advanced or previously untreated metastatic breast cancer. Participants will be randomized to 1 of 3 treatment arms (Arms A, B or C). Arm A will be open-label, whereas Arms B and C will be blinded.

NCT ID: NCT01116206 Completed - Constipation Clinical Trials

An Efficacy and Safety Study of Prucalopride in Participants With Chronic Constipation

Resolor
Start date: May 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy and safety of prucalopride to placebo (an inactive substance that is compared with a drug to test whether the drug has a real effect in a clinical trial) in treatment of participants with chronic (very serious, life threatening) constipation (decreased number of or difficulty making bowel [the intestine] movements).

NCT ID: NCT01115595 Completed - Clinical trials for Rhinitis, Allergic, Perennial

Efficacy of Allergen Immunotherapy for Allergic Rhinitis in Thais

Start date: March 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to study the efficacy of allergen injection immunotherapy for allergic rhinitis by - symptoms score - medication score - quality of life - immunologic test from blood

NCT ID: NCT01115543 Completed - Clinical trials for End Stage Renal Disease

Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary Hyperparathyroidism

Start date: August 2008
Phase: Phase 4
Study type: Interventional

This study was performed to determine whether calcitriol provides a therapeutic advantage to alfacalcidol for treatment of secondary hyperparathyroidism in ESRD patients.

NCT ID: NCT01114529 Completed - Clinical trials for Renal Transplantation

Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant Recipients

ELEVATE
Start date: August 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether an early Calcineurin Inhibitor (CNI) to everolimus conversion at 10-14 weeks post transplantation improves renal allograft function without compromising efficacy compared to standard CNI treatment in de novo renal allograft recipients. In addition, the study is designed to evaluate the impact of a CNI-free regimen on evolution of cardiovascular parameters in de novo renal allograft recipients